Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Long-Term Debt Repayments (2016 - 2025)

Immucell (ICCC) has disclosed Long-Term Debt Repayments for 16 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Debt Repayments rose 205.32% year-over-year to $1.1 million, compared with a TTM value of $2.3 million through Sep 2025, up 55.78%, and an annual FY2024 reading of $1.5 million, up 23.83% over the prior year.
  • Long-Term Debt Repayments was $1.1 million for Q3 2025 at Immucell, up from $381438.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $1.1 million in Q3 2025 and bottomed at $190377.0 in Q1 2021.
  • Average Long-Term Debt Repayments over 5 years is $326598.6, with a median of $251901.0 recorded in 2023.
  • The sharpest move saw Long-Term Debt Repayments tumbled 97.77% in 2021, then skyrocketed 205.32% in 2025.
  • Year by year, Long-Term Debt Repayments stood at $194905.0 in 2021, then grew by 27.35% to $248207.0 in 2022, then skyrocketed by 43.73% to $356759.0 in 2023, then rose by 4.9% to $374232.0 in 2024, then soared by 200.43% to $1.1 million in 2025.
  • Business Quant data shows Long-Term Debt Repayments for ICCC at $1.1 million in Q3 2025, $381438.0 in Q2 2025, and $380106.0 in Q1 2025.